Aug 15, 2024
Kent Wakeford, Co-CEO and Co-Founder of Form Bio, a company that provides computational solutions to scientists who are focused on cell and gene therapy to accelerate drug discovery and development, reduce costs, and ultimately make treatments more affordable for patients. Form Bio's in silico platform utilizes...
Aug 15, 2024
Kent Wakeford, Co-CEO and Co-Founder of Form Bio, a company that provides computational solutions to scientists who are focused on cell and gene therapy to accelerate drug discovery and development, reduce costs, and ultimately make treatments more affordable for patients. Form Bio's in silico platform utilizes...
Aug 7, 2024
Dr. Oren Cohen, President of Clinical Pharmacology and Chief Medical Officer at Fortrea, a global CRO spun-off from Labcorp, discusses the contract research environment and how it continues to change to meet the need for increased productivity in the development and testing of new drugs, devices, and treatments. One...
Aug 7, 2024
Dr. Oren Cohen, President of Clinical Pharmacology and Chief Medical Officer at Fortrea, a global CRO spun-off from Labcorp, discusses the contract research environment and how it continues to change to meet the need for increased productivity in the development and testing of new drugs, devices, and treatments. One...
Jul 8, 2024
Ed Esquenazi, Founder and CEO of Sirenas, is exploring the chemistry of marine organisms to accelerate drug discovery. Marine-based scientific elements are still poorly understood but have the potential to produce unique and useful compounds for drug development. There are stark differences between land-based organisms...